Home / Cancer and immune system / Mitomycin
ATC L01DC03 · Antineoplastic Agents
Mitomycin shortage
As of 31 Oct 2026, Mitomycin has a reported shortage in 3 of the 5 countries we track (Germany, Spain, Belgium), covering 6 products.
Countries3/5
Products6packs or presentations
Short since7 Nov 20197.0 years ago
Earliest return31 Oct 2026company estimate
No return date2products
Main reasonOther
Timeline
GermanySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Mitem 20mg | Substipharm | 18 Nov 2025 | 1 Feb 2027 | Other Sonstige |
| DE | Mitem 20mg | Substipharm | 18 Nov 2025 | 1 Feb 2027 | Other Sonstige |
| DE | Mitem 20mg | Substipharm | 18 Nov 2025 | 1 Feb 2027 | Other Sonstige |
| ES | MITOMICINA MEDAC 40 MG POLVO PARA SOLUCION INTRAVESICAL Y PARA SOLUCION INYECTABLE EFG, 1 vial | Medac Gesellschaft Für Klinische Spezialpräparate Gmbh | 7 Nov 2019 | not given | Not stated |
| ES | MITOMICINA ACCORD 20 MG POLVO PARA SOLUCION INTRAVESICAL Y PARA SOLUCION INYECTABLE , 1 vial de 20 mg | Accord Healthcare S.L.U. | 1 Dec 2019 | not given | Not stated |
| BE | Mitomycin Accord Healthcare 10 mg inj./inf. sol. (pwdr.)/i.vesic. sol. (pwdr.) i.v. vial 5 x 10 mg | Accord Healthcare | 28 Mar 2025 | 31 Oct 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.